Informational Posters - 2
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Resources for Clinical and Epidemiology Research from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Resources for Clinical and Epidemiology Research from the National Institute of Diabetes and Digestive and Kidney Diseases
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Funding Opportunities from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Funding Opportunities from the National Institute of Diabetes and Digestive and Kidney Diseases
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Training and Career Development Programs from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Training and Career Development Programs from the National Institute of Diabetes and Digestive and Kidney Diseases
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Supporting Health Equity Research and Building a Diverse and Inclusive Research Workforce from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Supporting Health Equity Research and Building a Diverse and Inclusive Research Workforce from the National Institute of Diabetes and Digestive and Kidney Diseases
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial to Assess the Safety and Efficacy of TIN816 in the Treatment of Adult Patients with Sepsis-Associated AKI
10:00 AM - 12:00 PM
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial to Assess the Safety and Efficacy of TIN816 in the Treatment of Adult Patients with Sepsis-Associated AKI
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with AKI Requiring Continuous Kidney Replacement Therapy
10:00 AM - 12:00 PM
NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with AKI Requiring Continuous Kidney Replacement Therapy
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- NEUTRALIZE-CRS: A Multicenter, Single-Arm, Open-Label Study to Assess a Selective Cytopheretic Device in Bridging Severe Heart Failure Patients to Left Ventricular Assist Device (LVAD) Implantation
10:00 AM - 12:00 PM
NEUTRALIZE-CRS: A Multicenter, Single-Arm, Open-Label Study to Assess a Selective Cytopheretic Device in Bridging Severe Heart Failure Patients to Left Ventricular Assist Device (LVAD) Implantation
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Belimumab and Rituximab Compared with Rituximab Alone for the Treatment of Primary Membranous Nephropathy (REBOOT)
10:00 AM - 12:00 PM
Belimumab and Rituximab Compared with Rituximab Alone for the Treatment of Primary Membranous Nephropathy (REBOOT)
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- ORIGIN 3: Pivotal Ph3 Study Evaluating Effect of Atacicept vs. Placebo on Proteinuria and Kidney Function Preservation in IgAN
10:00 AM - 12:00 PM
ORIGIN 3: Pivotal Ph3 Study Evaluating Effect of Atacicept vs. Placebo on Proteinuria and Kidney Function Preservation in IgAN
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- ORIGIN Extend: A Rollover Extension Study to Continue to Evaluate the Long-Term Safety and Efficacy of Atacicept
10:00 AM - 12:00 PM
ORIGIN Extend: A Rollover Extension Study to Continue to Evaluate the Long-Term Safety and Efficacy of Atacicept
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 1 Study of ADI-001, an Allogeneic CD20-Targeted γδ CAR T cell Therapy, in Adults with Autoimmune Disease
10:00 AM - 12:00 PM
A Phase 1 Study of ADI-001, an Allogeneic CD20-Targeted γδ CAR T cell Therapy, in Adults with Autoimmune Disease
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Progress and Promise: N-Acetylmannosamine (ManNAc) as a Therapy for Glomerular Diseases
10:00 AM - 12:00 PM
Progress and Promise: N-Acetylmannosamine (ManNAc) as a Therapy for Glomerular Diseases
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pediatric and Young Adult Populations with CKD: Protocol and Rationale for the Randomized Controlled SGLT2 Inhibitor Trial DOUBLE PRO-TECT Alport
10:00 AM - 12:00 PM
Pediatric and Young Adult Populations with CKD: Protocol and Rationale for the Randomized Controlled SGLT2 Inhibitor Trial DOUBLE PRO-TECT Alport
October 25, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
